Alternative driver pathways in peripheral nerve sheath tumors - including DICER1 and/or KRAS alterations

Hsin-Yi Chang1,2, Carla Saoud2, Dianne Torrence3

  • 1Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.

The Journal of Pathology
|January 23, 2025
PubMed

Insights

DICER1-mutant sarcomas can mimic malignant peripheral nerve sheath tumors (MPNSTs), particularly when KRAS mutations are present. This study identifies a subset of MPNSTs with DICER1 and/or KRAS alterations, distinct from conventional MPNSTs.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • DICER1-associated sarcomas are an emerging group of tumors characterized by DICER1 mutations.
  • Concurrent genetic alterations like TP53 inactivation and RAS pathway activation are common in these sarcomas.
  • Tumors resembling malignant peripheral nerve sheath tumors (MPNSTs) are rarely reported in DICER1 sarcomas and present diagnostic challenges.

Purpose of the Study:

  • To investigate the incidence of DICER1 and KRAS mutations in MPNSTs.
  • To compare the genomic and morphologic features of MPNSTs with DICER1-mutant sarcomas.
  • To characterize a specific subset of MPNSTs associated with DICER1 and/or KRAS alterations.

Main Methods:

  • Analysis of a molecular database for DICER1, KRAS, ATRX, TP53, NF1, and NF2 alterations in MPNSTs and DICER1-mutant sarcomas.
  • Morphologic evaluation of tumor samples.
  • DNA-based methylation profiling.

Main Results:

  • Three cases of MPNST with co-existing DICER1, ATRX, and KRAS G12V/A alterations were identified.
  • Eight of 38 (21%) DICER1-associated sarcomas harbored secondary KRAS hotspot mutations, with three showing MPNST-like histology.
  • DICER1-mutant sarcomas with TP53 mutations (10/38, 26%) displayed a pleomorphic phenotype, contrasting with the monomorphic cells in KRAS-mutated sarcomas.

Conclusions:

  • A distinct subset of MPNSTs associated with DICER1 and/or KRAS mutations exists.
  • These MPNSTs lack canonical NF1/NF2 alterations and exhibit monomorphic spindle cell morphology.
  • Further research is needed to clarify the relationship between these MPNSTs and conventional MPNSTs.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: